The role of anti-inflammatory drugs in the treatment of osteoarthritis: A United States viewpoint

Clinical and Experimental Rheumatology

Volumn 19, Issue 6 SUPPL. 25, 2001, Pages

  Moskowitz, R W ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Anti inflammatory agents; Osteoarthritis; Therapeutic guidelines; Treatment

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; HYALURONIC ACID DERIVATIVE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRAMADOL;

ARTHROPLASTY; ARTHROSCOPIC SURGERY; ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SELECTIVITY; EXERCISE; HUMAN; JOINT FUNCTION; LAVAGE; MEDICAL SCHOOL; ORTHOTICS; OSTEOARTHRITIS; OSTEOTOMY; PAIN ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RHEUMATOLOGY; STOMACH PROTECTION; SYMPTOM; UNITED STATES; WEIGHT REDUCTION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; IBUPROFEN; OSTEOARTHRITIS; PRACTICE GUIDELINES; UNITED STATES;

EID: 0034776176     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Synovial inflammation in patients with early osteoarthritis of the knee
2. Arthroscopic immunohistologic characterization of knee joint synovitis in osteoarthritis
3. Proinflammatory mediators and osteoarthritis
4. Cytokines and their role in the pathophysiology of osteoarthritis
5. Guidelines for the medical management of osteoarthritis. Osteoarthritis of the hip
6. Weight loss reduces the risk for symptomatic knee osteoarthritis in women
7. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program
8. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: The Fitness Arthritis and Senior Trial (FAST)
9. Recommendations for the medical management of osteoarthritis of the hip and knee
10. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
11. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable to that of diclofenac sodium: Results of a one-year, randomized clinical trial in patients with osteoarthritis of the knee or hip
12. Intra-articular sodium hyaluronate (Hyalgan®) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial
13. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference
14. North of England evidence-based guideline development project: Summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis
15. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in treatment of patients with osteoarthritis of the knee
16. The verdict favors non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis: A plea for more evidence on other treatments
17. Treatment of knee osteoarthritis: Relationship of clinical features of joint inflammation to the response to non-steroidal anti-inflammatory drug or pure analgesic
18. Severity of knee pain does not predict a better response to an anti-inflammatory dose of ibuprofen than analgesic therapy in patients with osteoarthritis
19. Osteoarthritis: Simple analgesics versus non-steroidal anti-inflammatory drugs
20. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of knee
21. A randomized double-blind crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the knees or hip
22. Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: A six-day double blind study
23. Preference for non-steroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1799 patients with osteoarthritis, rheumatoid arthritis and fibromyalgia
24. Preference for non-steroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis
25. Association of acetaminophen hepatoxicity with fasting and ethanol use
26. The risk of upper gastrointestinal complications associated with non-steroidal anti-inflammatory drugs, gluco-corticoids, acetaminophen, and combinations of these agents
27. The effects of salicylates and other non-steroidal anti-inflammatory drugs on articular cartilage
28. Celecoxib does not affect index joint x-rays in osteoarthritis (OA) patients with long-term exposure
29. Long-term effects of glucosamine sulphate on osteoarthritis progression: Randomized placebo controlled trial
30. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan®) in osteoarthritis of the knee